has signed an agreement to acquire Ateb, together with its Canadian affiliate Ateb Canada, Ltd. According to Omnicell, Ateb is the
industry’s leading provider of pharmacy-based patient care solutions and medication synchronization, with over 15,000 independent and chain
pharmacies in the United States and Canada using Ateb solutions. The shared portfolio supports the Omnicell mission of increasing patient
access to medication adherence solutions to simplify management of chronic conditions.
reported that it would acquire Ateb for approximately $41
million, subject to certain adjustments, in an all-cash transaction. Ateb recorded approximately $27 million in revenue during the 12-month
period ended Sept. 30, 2016.